FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Mar 17, 2022
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on March 17, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- March 17, 2022
- Product Type
- Biologics
View Company Profile
ID · 5722e8d4-b7f2-495b-bd9c-bd1123aa0458
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1167592
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Biomat USA, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 14, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 16, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 27, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 21, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1015150 - 2017-06-07
- FDA Inspection 903957 - 2014-11-14
- FDA Inspection 805513 - 2012-10-16
- FDA Inspection 722053 - 2011-04-27
- FDA Inspection 578255 - 2009-04-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.